Research Progress of Liquid Biopsy Based on DNA Methylation in Tumor Diagnosis and Treatment
- PMID: 39766341
- PMCID: PMC11727523
- DOI: 10.3390/biom14121634
Research Progress of Liquid Biopsy Based on DNA Methylation in Tumor Diagnosis and Treatment
Abstract
Liquid biopsy has been gradually applied to the clinical diagnosis and treatment of tumors because of its non-invasive and real-time reflection of the tumor status, as well as the convenience of sample collection, which allows the detection of primary or metastatic malignant tumors and reflects the heterogeneity of the tumors. DNA methylation, which is a type of epigenetic modification, is essential in the progression of tumors. This review introduces the common DNA methylation analysis methods and discusses their advantages and disadvantages, focusing on the new progress of DNA methylation-based liquid biopsy in tumor diagnosis and treatment.
Keywords: DNA methylation; epigenetic; liquid biopsy; tumor.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- 82472771,82273139, 82302641/the National Natural Science Foundation of China
- 22QA1408300/Shanghai Science and Technology Committee Rising-Star Program
- 2021YNZYY02/Excellent Talents Nurture Project of Shanghai Chest Hospital
- RC-202301-130/the Talent Training Plan of Shanghai Chest Hospital in 2022
- LHPD2304/High-level Local University Construction - Shanghai Jiao Tong University School of Medicine of Linghang pandeng Program
LinkOut - more resources
Full Text Sources
Medical
